Phase I Study of BEBT-209 in Women With Advanced Breast Cancer
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Advanced Breast Cancer
Interventions: DRUG: BEBT-209 capsules|DRUG: Letrozole tablets|DRUG: Fulvestrant
Sponsor: BeBetter Med Inc
Collaborators: Hunan Cancer Hospital|Xiangya Hospital of Central South University